Events
Dissertation: Awais Wahab
Opponent: Professor of Oral Pathology Elisabeth Bloemena, VU University Medical Center Amsterdam
Dissertation: Johanna Hietamäki
Opponent: professor Roland Pfäffle, University of Leipzig
Dissertation: Saeed Montazeri Moghadam
Opponent: Professor Maarten De Vos, KU Leuven
HiLIFE webinar / Biomedicum Helsinki seminar: Frédéric Saudou
From
Huntington Disease to neuronal transport: Vesicles have their on-board fueling
and navigational systems to self-direct and detoxify the axon
Short bio Frédéric Saudou, Professor of
Cell Biology at Grenoble University and director of the GIN from 2013 to 2023
is a leader in the fields of neurobiology of Huntington’s disease and
mechanisms of neurodegeneration. His research team “Intracellular Dynamics and
Neurodegeneration” studies the role of the huntingtin protein in intracellular
trafficking and how this function is perturbed in Huntington's disease with the
ultimate goal of developing compounds of therapeutic interest. Abstract Huntington’s disease (HD) is caused
by the abnormal polyglutamine expansion in the N-ter part of huntingtin (HTT),
a large protein of 350kDa. Over the past years, we proposed that HTT associates
to vesicles and acts a scaffold for the molecular motors and through this
function, regulates the efficiency and directionality of vesicular transport in
neurons. HTT controls the microtubule-based fast axonal transport (FAT) of
neurotrophic factors such as BDNF. Importantly, polyQ expansion in HTT alters
this function, leading to a decrease in neurotrophic support and death of
striatal neurons. By developing microfluidic
approaches allowing to study healthy and defective corticostriatal networks in
vitro that are compatible with high-resolution videomicroscopy and the use of
biosensors, we found that HTT scaffolds the whole glycolytic machinery on
vesicles to supply constant energy, independently of mitochondria, for the
transport of vesicles over long distances in axons. We also found that HTT by
activating specific signaling complexes ensures that certain types of vesicles
such as signaling endosomes find their way to the nucleus by having an on-board
navigational system. Importantly, we found that HTT could orchestrate different
energy supply pathways depending on the type of vesicles and the level of
cellular stress. We will discuss how these machineries are activated in
physiological situations and how they are altered in disease. For discussion slots with the speaker, contact
Anu Wartiovaara anu.wartiovaara@helsinki.fi For
student & postdoc lunch, contact Yilin Kang, Yilin.kang@helsinki.fi Welcome to this exciting seminar! Anu & Yilin Five recent publications 1. Mc Cluskey M, Dubouchaud H, Nicot
AS and Saudou F. A vesicular Warburg effect: Aerobic glycolysis occurs on
axonal vesicles for local NAD+ recycling and transport. Traffic. 2023
Dec 12. doi: 10.1111/tra.12926. PMID: 38084815 2. Vitet H, Bruyère J, Xu H, Séris C, Brocard
J, Abada YS, Delatour B, Scaramuzzino C, Venance L and Saudou F. Huntingtin
recruits KIF1A to transport synaptic vesicle precursors along the mouse axon to
support synaptic transmission and motor skill learning. Elife. 2023 Jul
11;12:e81011. doi: 10.7554/eLife.81011. PMID: 37431882 3. Scaramuzzino C, Cuoc EC, Pla P, Humbert S
and Saudou F. Calcineurin and huntingtin form a calcium-sensing machinery that
directs neurotrophic signals to the nucleus.Sci Adv. 2022 Sci Adv. 2022
Jan 7;8(1):eabj8812. doi: 10.1126/sciadv.abj8812. 4. Virlogeux A, Scaramuzzino C,
Lenoir S, Carpentier R, Louessard M, Genoux A, Lino P, Hinckelmann MV, Perrier
AL, Humbert S and Saudou F. Increasing brain palmitoylation rescues behavior
and neuropathology in Huntington disease mice. Sci Adv. 2021 Mar
31;7(14):eabb0799. doi: 10.1126/sciadv.abb0799. 5. Bruyère J, Abada YS,
Vitet HM, Fontaine G, Deloulme JC, Cës A, Denarier E, Pernet-Gallay K, Andrieux
A, Humbert S, Potier MC, Delatour B and Saudou F. Presynaptic APP
levels and synaptic homeostasis are regulated by Akt phosphorylation of
Huntingtin, eLife, 2020 May 26;9:e56371. doi: 10.7554/eLife.56371.
NanoString seminar
Biomedicum Functional Genomics Unit (FuGU) and NanoString invite you to join this seminar to find out how the nCounter®️ Analysis System empowers you to rapidly translate your basic science discoveries into actionable clinical insights.
nCounter technology provides a robust method for multiplexing up to 800 gene expression targets using direct detection technology. The simple, efficient workflow requires just 15 minutes hands-on time for most panels using an automated benchtop processing system and produces highly reproducible data, requiring no amplification or technical replicates in less than 24 hours. This workflow rapidly accelerates biomarker validation and biomarker development, providing gene expression data you can count on.
Would you like to meet our experts and see how nCounter can be used to answer important research and clinical questions with robust performance on even the most difficult sample types and unparalleled flexibility in content and throughput?
Agenda
13:00 – 13:05 | Registration |
13:05 – 13:15 | Introduction to Biomedicum Functional Genomics Unit (FuGU) Anne Mäkelä |
13:15 – 13:45 | nCounter Analysis System, Gene Expression you can count on Amanda Mason |
13:45 – 14:00 | Wrap up / Q&A |
From 14:00 onwards | Book a 1-2-1 project consultation |
If you have any questions, or to book your project consultation, please contact Reija Laitinen (rlaitinen@nanostring.com)